patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pautaotzu - the citation came for Emma's post...

Pautaotzu - the citation came for Emma's post...

posted on Nov 28, 2007 06:24AM

There are actually different requirements for different exchanges. Emma's post lists the requirements for listing on the NASDAQ.

The income requirement for the NASDAQ is an "either or" - meaning they don't have to meet the income requirement if they meet other specified requirements. Nevertheless, there is an income requirement stipulated in the NASDAQ listing requirements so I was correct.

The bottom line is that Pluristem needs to announce mega news that includes $$$$ coming into the company. If they don't have this news ready to be issued, they had no business doing an RS and trying for a NASDAQ listing at this time. Of course I hope they have this news ready to go. This is what EDIGOKIE was trying to warn us about. No big news and we sink like a lead balloon.

Share
New Message
Please login to post a reply